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Purpose: This study aims to investigate the additive effect of the Hedera helix 
(HH) and Rhizoma coptidis (RC) extracts mixture on antitussive and expectorant 
activities in animals. Materials and Methods: The expectorant assay was per-
formed with phenol red secretion in mice trachea. Mice or guinea pigs were ran-
domly divided into groups of 8 each, including negative and positive control 
groups. After gastric administration of the test extracts in mice, 2.5% phenol red 
solution (0.2 mL) was intraperitoneally injected. Trachea was dissected and optical 
density of tracheal secretion was measured. After gastric administration of the test 
extracts in guinea pigs, the antitussive activities were assessed using a citric acid-
induced cough measurement. Results: The extracts of HH and RC significantly 
increased tracheal secretion and inhibited cough. The mixture of HH and RC ex-
tracts in a 1:1 concentration at a dose of 200 mg/kg showed a more potent effect 
on phenol red secretion (25.25±3.14) and cough inhibition (61.25±5.36) than the 
individual use of each extracts [phenol red secretion; HH 13.39±4.22 (p=0.000), 
RC 20.78±2.50 (p=0.010), cough inhibition; HH 9.89±4.14 (p=0.010), RC 30.25± 
7.69 (p=0.000)]. A 3:1 ratio mixture of HH to RC demonstrated an optimal expec-
torant effect (p<0.001), and this mixture showed expectorant and antitussive ef-
fects in a dose-dependent manner. Conclusion: This study provides evidence for 
antitussive and expectorant effect of a 3:1 mixture of HH and RC, which may be a 
useful therapeutic option for respiratory diseases.
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INTRODUCTION
Even though coughing is a natural protective reflex to remove airway secretions 
and pathogens from the respiratory tract, it is one of the common symptoms asso-
ciated with chronic inflammatory disease of the respiratory tract such as asthma, 
chronic bronchitis, pneumonia and postnasal drip syndrome.1 At present, a cough 
can be regulated by medications such as codeine and dextromethorphan, which are 
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MATERIALS AND METHODS
Plant materials and chemicals
Dried leaf of HH and dried RC were purchased at the Kyung-
dong herbal market in Seoul and were identified by Prof. 
Kang Ro Lee (Sungkyunkwan University, Suwon, Korea). 
The voucher specimens of HH and RC were preserved un-
der the reference number SKKU-NPL 1226 and 1227 at the 
Herbarium of Natural Products Laboratory, School of Phar-
macy, Sungkyunkwan University. Ambroxol, phenol red, 
theobromine, and citric acid were purchased from Sigma 
Chemical Co. (St. Louis, MO, USA).
 
Preparation of the extracts
Dried leaf of HH was percolated with 30% ethanol for 6 
hours. Then, the ethanol extract was spray-dried. RC was 
refluxed twice with water-saturated butanol at 80°C, each 
for 5 hours and 3 hours. Subsequently, the percolating ma-
terial, such as ethanol or butanol, was removed via spray-
drying or vacuum evaporization technique. The final solid 
extract was obtained via freeze-drying technique. The yields 
of dried extracts as a percentage weight of HH and RC 
were 14.5% and 15.7%, respectively.
Expectorant assay using phenol red secretion in mice 
trachea
Eight week-old male ICR mice were purchased from Orient 
Bio Inc. (Gapyeong, Korea). The animals were housed at 
room temperature (23±3°C) with constant humidity (55± 
15%) under a 12 hour light-dark cycle with food and water 
available ad libitum. After 3‒5 days of adaptation, the eligi-
ble animals were randomly divided into groups of 8 mice 
each, including negative and positive (ambroxol) control 
groups. All procedures involving animals were conducted 
at facilities of the Gyeonggi Bio-Center (Suwon, Korea), 
and all protocols were approved by the Institutional Ethical 
Committee of the Gyeonggi Bio-Center. The procedures 
were carried out as described previously.12,13 Briefly, each 
natural product extract was administered via the gastric 
route. Thirty minutes after gastric administration of the test 
extracts, 2.5% phenol red solution (0.2 mL) was intraperi-
toneally injected. Then, 30 minutes after the application of 
phenol red, the mice were sacrificed. Trachea was dissected 
and immediately placed into 1 mL of normal saline. After 
the trachea was washed, 0.1 mL of 1 M NaOH was added 
to the saline and the optical density was measured at 546 
associated with side effects including drug dependency or 
drowsiness. Sputum tenacity, which results in adhesiveness 
and cohesiveness of sputum, considerably influences the 
clearance of sputum.2 An expectorant is a drug that is thought 
to increase the hydration of either mucus or the periciliary 
fluid.3 Although increasing hydration of the sputum itself 
will not improve clearance in the case of depleted airway 
surface liquid, improving the hydration of this surface fluid 
may detach secretions from the epithelium, thus decreasing 
tenacity and improving transportability and clearance of 
sputum.4,5 Therefore, there is an increasing demand for 
drugs that promote antitussive and expectorant activities 
with fewer adverse effects.
Hedera helix (common ivy, English ivy, European ivy, or 
just ivy: HH) has been used for centuries to treat diverse 
diseases as folk medicine in Europe. Decoctions made from 
the leaves of HH were used during the 19th century to treat 
catarrh of the respiratory tract. Nowadays the dry extract of 
HH is commercially formulated, and many positive studies 
have been published to prove that this extract is an effective 
and well-tolerated therapeutics in both children and adults 
suffering from respiratory diseases.6 Sieben, et al.7 reported 
that the secretolytic effects of HH extract are due to its sa-
ponin contents, particularly α hederin, as an inhibitor of the 
β2 receptors endocytosis. Moreover, the same group also 
elucidated that α hederin has bronchodilatory effect in bo-
vine trachea via the same mechanism.8 
In traditional medicine, many natural products have been 
used to treat cough and sputum for thousands of years, and 
have shown minimal side effects.9 Thus, it is valuable to 
search for effective treatments for both cough and sputum 
among natural products because of their low toxicity and 
fewer side effects. We reported that berberine suppresses 
the expression of MUC5AC gene, one of the major mucin 
producing genes in chronic inflammatory airway diseases,10 
and Sánchez-Mendoza, et al.11 showed that berberine has 
bronchodilatory activity. Through these works, we postulat-
ed that medicinal plants of which major constituent is ber-
berine, and which have been prescribed for respiratory in-
flammatory diseases in traditional Chinese medicine, may 
show expectorant effect and antitussive effect. In this study, 
therefore, Rhizoma coptidis (RC) was selected, and we in-
vestigated expectorant and antitussive effect of each HH 
and RC extract. If any positive effects were observed in in-
dividual extract, additive effects of HH and RC extract mix-
ture were investigated.
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acid under conscious condition for 10 minutes. Then, each 
guinea pig was placed in a 2 L glass chamber with a plethys-
mograph system and the number of coughs was counted for 
15 minutes. The antitussive activities were expressed as the 
percentage of inhibition of the number of coughs in terms of 
that in control groups by using the following equation: the 
percentage of inhibition=[(C0-Ct)/C0×100] (C0: the number 
of coughs of the negative control, Ct: the number of coughs 
of the treatment group). Thus, the data represent a percentage 
of cough inhibition by each agent. The data were analyzed 
by Kruskal-Wallis test and Mann-Whitney test for signifi-
cance among groups. Statistical analyses were performed by 
using SPSS version 18.0.
RESULTS
 
Expectorant and antitussive effect of each extract
In the expectorant and antitussive assay, each extract was 
administered via gastric route at a dose of 100 and 200 mg/
kg. The expectorant and antitussive effect of HH and RC 
was compared with the negative control and the results are 
listed in Table 1. No serious adverse event, such as liver 
failure or renal failure which leads to death, was found dur-
ing the study.
Additive effect of the mixture of HH and RC extracts 
on expectoration and cough inhibition 
To examine their additive effect, a single treatment was 
compared to a mixture of HH and RC extracts for expecto-
ration and cough inhibition. In the expectorant assay, a mix-
nm using a microplate reader (Molecular Devices, Sunny-
vale, CA, USA). Data were expressed as a percentage of the 
optical density of each experimental sample compared to 
that of the negative control (being derived from a mouse tra-
chea not treated with any agent). The expectorant activities 
were assessed by the increase of the optical density in terms 
of that in negative control groups by using the following 
equation: the percentage of increase=[(Dt-D0)/D0×100] (D0: 
the optical density of negative control, Dt: the optical densi-
ty of the treatment group). Thus, data represent a percent-
age of increased sputum clearance by each agent. The data 
were analyzed by Kruskal-Wallis test and Mann-Whitney 
test for significance among groups. Statistical analyses were 
performed by using SPSS version 18.0 (SPSS Inc., Chica-
go, IL, USA).
Antitussive assay using citric acid-induced cough in 
guinea pig
Six week-old Hartley male guinea pigs, weighing 360‒380 
g, were purchased from Daehan Biolink Co. (Daejeon, Ko-
rea). The animals were housed at room temperature (23± 
3°C) with constant humidity (55±15%) under a 12 hour 
light-dark cycle with food and water available ad libitum. 
After 3‒5 days of adaptation, the eligible animals were ran-
domly divided into groups of 8 guinea pigs each, including 
negative and positive (theobromine) control groups. An aero-
sol delivery system (Buxco Electronics, Wilmington, NC, 
USA) was used for this experiment. The cough reflex was 
induced as described previously with modification.14 Briefly, 
60 minutes after gastric administration of drugs, the guinea 
pigs were exposed to a nebulized solution of 0.2 M citric 
Table 1. Effect of Hedera helix (HH), Rhizoma coptidis (RC) Extracts and the Mixture of HH and RC on Phenol Red Secretion 
and Cough Inhibition According to Dose
Group Increase of phenol red secretion (%) Cough inhibition (%)
Positive control
    Ambroxol (250 mg/kg) 25.80±2.41 -
    Theobromine (50 mg/kg) - 53.22±5.66
100 mg/kg
    HH   5.33±6.79   30.00±11.62
    RC   8.84±3.17 24.58±9.12
    HH+RC (1:1 mixture) 14.81±4.45 46.97±5.49
200 mg/kg
    HH 13.39±4.22 39.89±4.14
    RC 20.78±2.50 30.25±7.69
    HH+RC (1:1 mixture) 25.25±3.14 61.25±5.36
All data were compared to the negative control group and were shown as the mean±standard deviation. For the phenol red secretion experiment, each 
group was composed of 8 mice and 64 mice were used in total including negative control. For the cough inhibition experiment, each group was composed 
of 8 guinea pigs and 64 guinea pigs were used in total including negative control. 
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1:1 mixture of HH and RC showed more potency than the 
positive control at a dose of 200 mg/kg (p=0.038).
Optimal mixing ratio and dose of HH and RC extracts
Since 200 mg/kg of the 1:1 mixture of HH and RC extracts 
showed an additive effect, we attempted to find an optimal 
mixing ratio for additive expectorant and antitussive effect. 
Thus, multiple mixing ratios of HH and RC (200 mg/kg) 
were examined. At a dose of 200 mg/kg, a 3:1 ratio of HH 
to RC showed a maximal expectorant effect and was statis-
tically significantly more potent than the positive control 
(p<0.001) (Table 2, Fig. 2). Thus, this 3:1 ratio was used in 
the following experiments.
To determine an optimal dose of a 3:1 ratio mixture of HH 
ture of HH and RC extracts in a 1:1 concentration signifi-
cantly increased phenol red secretion in a dose-dependent 
manner, and this increase was much more than that in the 
use of the extracts individually (at a dose of 200 mg/kg; 
p=0.000 compared to HH, p=0.010 compared to RC). How-
ever, phenol red secretion of 1:1 mixture of HH and RC 
showed no significant difference compared the positive con-
trol at a dose of 200 mg/kg (p=0.721) (Table 1, Fig. 1A). In 
the antitussive assay, a mixture of HH and RC extracts in a 
1:1 concentration significantly inhibited cough in a dose-
dependent manner, and this inhibition was also much more 
than that in the use of the extracts individually (at a dose of 
200 mg/kg; p=0.010 compared to HH, p=0.000 compared 
to RC) (Table 1, Fig. 1B). Furthermore, cough inhibition of 
Fig. 1. Effect of Hedera helix (HH), Rhizoma coptidis (RC) extracts and the mixture of HH and RC on phenol red secretion and cough inhibition according to 
the dose. (A) The expectorant assay using phenol red secretion. A mixture of HH and RC extracts in a 1:1 concentration significantly increased phenol red 
secretion in a dose-dependent manner, and this increase was more significant than the use of the extracts individually. (B) The antitussive assay using citric 
acid-induced cough. A mixture of HH and RC extracts in a 1:1 concentration significantly inhibited cough in a dose-dependent manner, and this increase 
was also more significant than the use of the extracts individually. PC, the positive control group. *p<0.05, †p<0.01, ‡p<0.001.
Table 2. Effect of the Mixture of Hedera helix (HH) and Rhi-
zoma coptidis (RC) Extracts on Phenol Red Secretion Ac-
cording to Various Mixing Ratios
Group Increase of phenol red secretion (%)
Positive control (ambroxol 250 mg/kg) 25.55±2.06
    HH 200 mg/kg 13.20±5.23
    RC 200 mg/kg 21.87±2.31
HH:RC mixture 200 mg/kg
    1:1 22.35±2.81
    2:1 23.34±2.28
    3:1 27.48±4.45
    4:1 19.74±2.92
    5:1 15.19±2.73
All data were compared to the negative control group and were shown as 
the mean±standard deviation. Each group was composed of 8 mice and 
72 mice were used in total including negative control.
Fig. 2. Effect of mixture of Hedera helix (HH) and Rhizoma coptidis (RC) ex-
tracts on phenol red secretion according to various mixing ratios. A 3:1 ra-
tio of HH to RC showed a maximal expectorant effect. PC, the positive con-
trol group. *p<0.001.
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creasing demand for drugs with more potency and fewer 
side effects.6 In the present study, therefore, we investigated 
the interaction between HH and RC.
Each extract showed significant cough inhibition and ex-
pectorant effects. We investigated whether an HH and RC 
mixture (at a 1:1 concentration) shows a more potent ex-
pectorant and antitussive effect than the use of extracts indi-
vidually. The results showed that the HH and RC mixture 
had more potent effects in the expectoration and antitussive 
assays compared to the extracts individually in a dose-de-
pendent manner. Therefore, the HH and RC mixture seemed 
to be a strong candidate in developing an effective expecto-
rant and antitussive agent. As for the optimal mixing ratio 
of HH and RC extracts, a 3:1 mixture of HH and RC showed 
a potent effect at a dose of 200 mg/kg.
These expectorant and antitussive effects of HH and RC 
are most likely due to their major components such as sa-
ponin and berberine, respectively. Saponins (hederacoside 
C and α hederin), flavonoid (rutin), and phenolic deriva-
tives (chlorogenic acid) are the main components of the dry 
and RC extracts, various doses were examined. The mixture 
of HH and RC extracts showed a dose-dependent increase of 
phenol red secretion and inhibition of cough (p<0.001). Even 
though there was no significant difference from the positive 
control (p>0.05), the effect of this mixture on expectoration 
was as much potent as that of the positive control at a dose of 
200 mg/kg (Table 3, Fig. 3A), while the effect of this mixture 
on cough inhibition was statistically more potent than that of 
the positive control at a dose of 200 mg/kg (p<0.001) (Table 
3, Fig. 3B). Therefore, the optimal dose of a 3:1 ratio mixture 
of HH and RC extracts for both expectorant and antitussive 
effect was determined as 200 mg/kg.
DISCUSSION
There has been a great effort to utilize natural products as 
medications that have been traditionally used for thousands 
of years. Currently, dried leaf of HH extract is commercial-
ly used as an antitussive agent. Nevertheless, there is an in-
Table 3. Effect of the 3:1 Ratio Mixture of Hedera helix (HH) and Rhizoma coptidis (RC) Extracts on Phenol Red Secretion and 
Cough Inhibition According to Dose
Group Increase of phenol red secretion (%) Cough inhibition (%) 
HH+RC (3:1 mixture)
    25 mg/kg 13.64±3.81   34.86±12.37
    50 mg/kg 11.59±5.43   35.80±11.74
    100 mg/kg 14.81±5.39 58.64±5.85
    200 mg/kg 27.48±4.45 73.02±4.02
All data were compared to the negative control group and were shown as the mean±standard deviation. For the phenol red secretion experiment, each 
group was composed of 8 mice and 40 mice were used in total including negative control. For the cough inhibition experiment, each group was composed 
of 8 guinea pigs and 40 guinea pigs were used in total including negative control.
Fig. 3. Effect of 3:1 ratio mixture of Hedera helix (HH) and Rhizoma coptidis (RC) extracts on phenol red secretion and cough inhibition according to dose. (A) 
In the expectorant assay using phenol red secretion, a mixture of HH and RC extracts in a 3:1 concentration showed dose-dependent increase of phenol red 
secretion. (B) In the antitussive assay using citric acid-induced cough, a mixture of HH and RC extracts in a 3:1 concentration significantly inhibited cough in 
a dose-dependent manner. PC, the positive control group. *p<0.001.
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extract of HH. Approximately 10% of the HH extract con-
sists of a complex mixture of saponins, and the expectorant 
activity of saponins had been thought to be mediated by the 
gastric mucosa, with reflex stimulation of the bronchial mu-
cous glands via the parasympathetic pathway. Recently, α 
hederin, one of the major components of HH saponins, has 
been shown to inhibit the inactivation of β2 receptors in the 
lungs and bronchi. It is, therefore, likely that more function-
ing receptors are present on the surface of the cell and the 
adrenaline present can have a greater effect.7 HH saponins 
have also been shown to have spasmolytic, bronchodilatory 
and antibacterial activities.8,15,16
RC is a widely used traditional Chinese medicine. Many 
studies have demonstrated that RC has a wide range of phar-
macological properties, such as analgesic, anti-inflammato-
ry and antibacterial activities.17-20 RC has various alkaloids 
constituent, such as berberine, coptisine, palmatine and epi-
berberine.21 Among them, berberine is the most important 
and potent constituent. It has been reported that berberine 
has bronchodilatory and antimicrobial activities.11,22 An ad-
ditional action of berberine is to inhibit the mucin compo-
nent of sputum. Through the ERK- and p38 MAPK-depen-
dent signal transduction pathways, berberine has been shown 
to suppress IL1β-induced MUC5AC gene expression in hu-
man airway epithelial cells,10 suggesting that berberine can 
inhibit mucin production in sputum as well as having ex-
pectorant and antitussive effects. These mechanisms are 
most likely involved in both expectorant and antitussive ef-
fects of the extracts of HH and RC.
In the present study, we showed that HH and RC extracts 
mixture had good expectorant and antitussive effects in ani-
mal models and the optimal mixing ratio was 3:1 ratio of 
HH and RC. The present study is expected to provide con-
vincing evidence for the 3:1 HH and RC mixture to be used 
as one antitussive and expectorant medicine. However, fur-
ther study in human population should be followed. 
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